Carl B Ziegler, Jr

Title: The Innovations of Carl B Ziegler, Jr.

Introduction

Carl B Ziegler, Jr. is a notable inventor based in East Lyme, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for forming amorphous atorvastatin. With a total of 3 patents to his name, Ziegler's work has had a meaningful impact on drug formulation.

Latest Patents

Ziegler's latest patents focus on a process for forming amorphous atorvastatin. This innovative process involves dissolving atorvastatin in a non-hydroxylic solvent and subsequently removing the solvent through freeze-drying. Additionally, he has developed methods for dissolving atorvastatin in a hydroxylic solvent with the aid of a solubilizing agent, alkalizing agent, or antioxidant, followed by freeze-drying to achieve amorphous atorvastatin.

Career Highlights

Ziegler is currently associated with Pfizer Corporation, a leading pharmaceutical company. His work at Pfizer has allowed him to explore and refine his innovative processes, contributing to advancements in drug formulation and delivery.

Collaborations

Throughout his career, Ziegler has collaborated with esteemed colleagues, including Antone John deBettencourt, III, and Evgenyi Y Shalaev. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Carl B Ziegler, Jr. exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the formulation of amorphous atorvastatin, highlight the importance of research and collaboration in advancing medical science.